BioSpectrum Asia Magazine - February 2023![Add to My Favorites Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
BioSpectrum Asia Magazine - February 2023![Add to My Favorites Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Go Unlimited with Magzter GOLD
Read BioSpectrum Asia along with 8,500+ other magazines & newspapers with just one subscription View catalog
1 Month $9.99
1 Year$99.99 $49.99
$4/month
Subscribe only to BioSpectrum Asia
1 Year$11.88 $7.99
Buy this issue $0.99
In this issue
CANCER THERAPEUTICS GAINING GROUND IN APAC
Cancer, the leading cause of death in most parts of the world, is a veritable Achilles heel for the pharma industry. Not surprising that pharma companies continue to dedicate a significant part of their R&D budget for Oncology. Cancer medicine spending rose to $185 billion globally in 2021 and is expected to reach more than $300 billion by 2026, as per IQVIA. China’s oncology spending now exceeds the rest of emerging countries and is driven by expanded access to new therapies
and offset by lower prices. Chinese and other Asian cancer drug developers are at the forefront of driving innovation in this space. The focus of cancer treatment is rapidly shifting from a traditional one-size-fits-all approach to precision medicine, tailored treatments for individual patients. The next wave of innovations making headlines in the cancer space include immunotherapies, vaccines, CAR-T therapies, PD-1/L1 inhibitors, light-activated drugs etc. Many drug makers in Asia are investing in new science and hope to develop the next holy grail in oncology. Let’s take a deep
dive into the status of cancer drug research and development in the Asia Pacific (APAC).
New Zealand approves new therapy to treat rare gastrointestinal stromal tumour
Specialised Therapeutics Asia (ST), based in Singapore, has announced that a new therapy to treat rare gastrointestinal stromal tumour (GIST) shown to improve survival has now been approved in New Zealand.
![New Zealand approves new therapy to treat rare gastrointestinal stromal tumour](https://reseuro.magzter.com/100x125/articles/11639/1211531/QOjMUT9IK1675670221046/NEW-ZEALAND-APPROVES-NEW-THERAPY-TO-TREAT-RARE-GASTROINTESTINAL-STROMAL-TUMOUR.jpg)
1 min
Indonesia's TB response gets $300 M programme World Bank loan
The World Bank’s Board of Executive Directors has approved a $300 million loan to the Indonesian government to improve coverage, quality and efficiency of tuberculosis (TB) response in Indonesia.
![Indonesia's TB response gets $300 M programme World Bank loan](https://reseuro.magzter.com/100x125/articles/11639/1211531/ZxnOMFSYB1675670098987/INDONESIAS-TB-RESPONSE-GETS-300-M-PROGRAMME-WORLD-BANK-LOAN.jpg)
1 min
SK bioscience's shingles vaccine receives biologics license application approval in Malaysia
SKYZoster is shown clinically acceptable immunogenicity and safety at Phase III clinical trial.
![SK bioscience's shingles vaccine receives biologics license application approval in Malaysia](https://reseuro.magzter.com/100x125/articles/11639/1211531/A538q2uZi1675670372353/SK-BIOSCIENCES-SHINGLES-VACCINE-RECEIVES-BIOLOGICS-LICENSE-APPLICATION-APPROVAL-IN-MALAYSIA.jpg)
1 min
Mobile app to help adolescents access public health services in Bangladesh
Millions of adolescents and youth in Bangladesh will be able to access health information and services through two online portals launched recently at The National Adolescent Health Conference held in Dhaka.
![Mobile app to help adolescents access public health services in Bangladesh](https://reseuro.magzter.com/100x125/articles/11639/1211531/jVGk6JBgy1675670326291/MOBILE-APP-TO-HELP-ADOLESCENTS-ACCESS-PUBLIC-HEALTH-SERVICES-IN-BANGLADESH.jpg)
1 min
Lotte Biologics announces $3 B investment plan to leap forward as global CDMO
Lotte Biologics CEO Richard Wonjik Lee has announced a blueprint to leap forward as a global contract development and manufacturing organisation (CDMO).
![Lotte Biologics announces $3 B investment plan to leap forward as global CDMO](https://reseuro.magzter.com/100x125/articles/11639/1211531/hGn0jlzTb1675670511898/LOTTE-BIOLOGICS-ANNOUNCES-3-B-INVESTMENT-PLAN-TO-LEAP-FORWARD-AS-GLOBAL-CDMO.jpg)
1 min
Sun Pharma buys US-based Concert Pharma for $576 M
Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the US Food and Drug Administration (FDA) in the first half of 2023.
![Sun Pharma buys US-based Concert Pharma for $576 M](https://reseuro.magzter.com/100x125/articles/11639/1211531/n0r2EZKEB1675670431855/SUN-PHARMA-BUYS-USBASED-CONCERT-PHARMA-FOR-576-M.jpg)
1 min
Aculys Pharma, Four H initiate collaboration using wearable devices to study sleep disorders in Japan
In its quest to establish a new pharmaceutical model, Aculys is promoting DX (digital transformation) in clinical trials and medicine.
![Aculys Pharma, Four H initiate collaboration using wearable devices to study sleep disorders in Japan](https://reseuro.magzter.com/100x125/articles/11639/1211531/BWpU1EZh-1675670610242/ACULYS-PHARMA-FOUR-H-INITIATE-COLLABORATION-USING-WEARABLE-DEVICES-TO-STUDY-SLEEP-DISORDERS-IN-JAPAN.jpg)
1 min
Terumo and Siemens Healthineers collaborate to strengthen cardiac care in India
The collaboration will flag off its efforts with a customised training programme for Cathlab professionals, being developed in partnership with an eminent academic institute in India.
![Terumo and Siemens Healthineers collaborate to strengthen cardiac care in India](https://reseuro.magzter.com/100x125/articles/11639/1211531/cN1KLwE8g1675670681982/TERUMO-AND-SIEMENS-HEALTHINEERS-COLLABORATE-TO-STRENGTHEN-CARDIAC-CARE-IN-INDIA.jpg)
1 min
Seno Medical enters exclusive distributor agreement with Genetik
Seno Medical, based in the US, has entered into an exclusive distributor agreement with Genetik, to market, sell and service the company’s groundbreaking Imagio Opto-Acoustic/ Ultrasound (OA/US) Breast Imaging System.
![Seno Medical enters exclusive distributor agreement with Genetik](https://reseuro.magzter.com/100x125/articles/11639/1211531/guHVWh18m1675670824885/SENO-MEDICAL-ENTERS-EXCLUSIVE-DISTRIBUTOR-AGREEMENT-WITH-GENETIK.jpg)
1 min
Malaysian Genomics explores R&D collaboration with SIRIM
Under the strategic cooperation, both parties will evaluate the potential commercial value of a range of genomicsdriven biotechnology R&D projects.
![Malaysian Genomics explores R&D collaboration with SIRIM](https://reseuro.magzter.com/100x125/articles/11639/1211531/qH0WurRbG1675670774323/MALAYSIAN-GENOMICS-EXPLORES-RD-COLLABORATION-WITH-SIRIM.jpg)
1 min
Moderna buys Japanese startup OriCiro for $85M
OriCiro Genomics, founded in December 2018, is focussed on the development and commercialisation of cellfree synthesis
![Moderna buys Japanese startup OriCiro for $85M](https://reseuro.magzter.com/100x125/articles/11639/1211531/-_0wxhbMJ1675670957426/MODERNA-BUYS-JAPANESE-STARTUP-ORICIRO-FOR-85M.jpg)
1 min
China's ReLive Biotechnologies strengthens presence in regenerative therapy market
Simultaneously with the acquisition, ReLive also completed its Series A financing of $36 million to fund the company’s global ambition.
![China's ReLive Biotechnologies strengthens presence in regenerative therapy market](https://reseuro.magzter.com/100x125/articles/11639/1211531/mcDCLiJMc1675670872591/CHINAS-RELIVE-BIOTECHNOLOGIES-STRENGTHENS-PRESENCE-IN-REGENERATIVE-THERAPY-MARKET.jpg)
1 min
DeepTek introduces new Al powered lumbar spine quantification automation tool
India-based health tech startup DeepTek has announced the global launch of DeepSpine - an artificial intelligence (AI) powered lumbar spine quantification and metrics tool designed to analyse MRI lumbar spine images.
![DeepTek introduces new Al powered lumbar spine quantification automation tool](https://reseuro.magzter.com/100x125/articles/11639/1211531/VWX12u8du1675671071508/DEEPTEK-INTRODUCES-NEW-AL-POWERED-LUMBAR-SPINE-QUANTIFICATION-AUTOMATION-TOOL.jpg)
1 min
Veradigm announces strategic investment in Holmusk from Singapore
US-based Veradigm has announced an investment in Holmusk, a global behavioural health real-world evidence and data analytics company in Singapore, as part of Holmusk’s $45 million series B financing round.
![Veradigm announces strategic investment in Holmusk from Singapore](https://reseuro.magzter.com/100x125/articles/11639/1211531/YZGGb8XPK1675671132989/VERADIGM-ANNOUNCES-STRATEGIC-INVESTMENT-IN-HOLMUSK-FROM-SINGAPORE.jpg)
1 min
Addressing Unmet Patient Needs in Antimicrobial Resistance (AMR): The Vital Role of Industry Partnerships
Interview- Mr Maurizio Luongo and Mr Zhao Hong
![Addressing Unmet Patient Needs in Antimicrobial Resistance (AMR): The Vital Role of Industry Partnerships](https://reseuro.magzter.com/100x125/articles/11639/1211531/KTazq9uXp1675671199383/ADDRESSING-UNMET-PATIENT-NEEDS-IN-ANTIMICROBIAL-RESISTANCE-AMR-THE-VITAL-ROLE-OF-INDUSTRY-PARTNERSHIPS.jpg)
6 mins
CANCER THERAPEUTICS GAINING GROUND IN APAC
Cancer, the leading cause of death in most parts of the world, is a veritable Achilles heel for the pharma industry.
![CANCER THERAPEUTICS GAINING GROUND IN APAC](https://reseuro.magzter.com/100x125/articles/11639/1211531/IAaGv5EO11675675017118/CANCER-THERAPEUTICS-GAINING-GROUND-IN-APAC.jpg)
10+ mins
"Technology will play a significant role in reducing numbers of new cases and deaths"
‘Close the care gaps’ – a bold theme set for 2022-2024 World Cancer Day campaigns that fall on February 4 each year – intends to make a huge difference in delivering cancer care to the people.
!["Technology will play a significant role in reducing numbers of new cases and deaths"](https://reseuro.magzter.com/100x125/articles/11639/1211531/Iec9WojT_1675676535992/TECHNOLOGY-WILL-PLAY-A-SIGNIFICANT-ROLE-IN-REDUCING-NUMBERS-OF-NEW-CASES-AND-DEATHS.jpg)
5 mins
"We need to foster risky projects that can have large rewards"
Synthetic lethality is a promising area of cancer therapy. Anticancer Bioscience (ACB) is a precision oncology company, applying synthetic lethal approaches to develop targeted cancer therapies.
!["We need to foster risky projects that can have large rewards"](https://reseuro.magzter.com/100x125/articles/11639/1211531/XiEzIRz0v1675676789017/WE-NEED-TO-FOSTER-RISKY-PROJECTS-THAT-CAN-HAVE-LARGE-REWARDS.jpg)
4 mins
"Global investors can leverage our deep immunomics platform to develop TCR Cell therapies for solid tumours"
The global biotech ecosystem continues to fluctuate and pose fresh challenges but many emerging enterprises and technologies are keen to collaborate with other stakeholders to solve healthcare challenges.
!["Global investors can leverage our deep immunomics platform to develop TCR Cell therapies for solid tumours"](https://reseuro.magzter.com/100x125/articles/11639/1211531/H14Pr70EY1675676982253/GLOBAL-INVESTORS-CAN-LEVERAGE-OUR-DEEP-IMMUNOMICS-PLATFORM-TO-DEVELOP-TCR-CELL-THERAPIES-FOR-SOLID-TUMOURS.jpg)
5 mins
How Imaging Tech And Liquid Biopsy Will Play Pivotal Role In Cancer Care
A core tenet of precision medicine is to simplify the delivery of the right treatment to the right patient at the right dose and at the right time.
![How Imaging Tech And Liquid Biopsy Will Play Pivotal Role In Cancer Care](https://reseuro.magzter.com/100x125/articles/11639/1211531/wF3XtGIrm1675677187088/crp_HOW-IMAGING-TECH-AND-LIQUID-BIOPSY-WILL-PLAY-PIVOTAL-ROLE-IN-CANCER-CARE.jpg)
5 mins
"We're dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial"
Rare diseases remain untreatable globally despite major advances in research that have enabled us to understand their molecular basis, as well as legislation that provides regulatory and economic incentives to encourage their development.
!["We're dedicated to Multiple Sclerosis with two approved therapies and Evobrutinib currently in phase 3 trial"](https://reseuro.magzter.com/100x125/articles/11639/1211531/mJ8XD247b1675677323397/WERE-DEDICATED-TO-MULTIPLE-SCLEROSIS-WITH-TWO-APPROVED-THERAPIES-AND-EVOBRUTINIB-CURRENTLY-IN-PHASE-3-TRIAL.jpg)
5 mins
"Australia is poised to establish itself as a global life sciences hub"
Synthetic biology markets are experiencing a surge in demand for molecular diagnostics and technological advances in molecular biology, spurring growth in the Assay and Reagent market in Asia Pacific.
!["Australia is poised to establish itself as a global life sciences hub"](https://reseuro.magzter.com/100x125/articles/11639/1211531/YX-nDpf8n1675677447786/AUSTRALIA-IS-POISED-TO-ESTABLISH-ITSELF-AS-A-GLOBAL-LIFE-SCIENCES-HUB.jpg)
4 mins
VALUE is the Trending Word of 2023
The last two years saw a significant leap toward patient-centricity in the pharmaceutical space. although this next iteration will focus on leveraging the industry's growing digital maturity to offer increased patient value while achieving measurable business goals.
![VALUE is the Trending Word of 2023](https://reseuro.magzter.com/100x125/articles/11639/1211531/0a8WtoRl91675677883617/VALUE-IS-THE-TRENDING-WORD-OF-2023.jpg)
5 mins
Goa Institute of Management launches professional certificate programme in healthcare
Goa Institute of Management (GIM) in India has launched a Professional Certificate Programme in Healthcare Management powered by Asia’s largest higher Edtech Company, upGrad.
![Goa Institute of Management launches professional certificate programme in healthcare](https://reseuro.magzter.com/100x125/articles/11639/1211531/wbOhcmNRd1675678215850/GOA-INSTITUTE-OF-MANAGEMENT-LAUNCHES-PROFESSIONAL-CERTIFICATE-PROGRAMME-IN-HEALTHCARE.jpg)
1 min
Singapore unveils talent development strategy to boost Healthtech and Biotech ecosystem
Considering Singapore’s RIE2025 initiative, SGInnovate’s Helix Immersion Programme will support Singapore’s growing biomedical and biotech companies.
![Singapore unveils talent development strategy to boost Healthtech and Biotech ecosystem](https://reseuro.magzter.com/100x125/articles/11639/1211531/yh1lnY3s21675678152387/SINGAPORE-UNVEILS-TALENT-DEVELOPMENT-STRATEGY-TO-BOOST-HEALTHTECH-AND-BIOTECH-ECOSYSTEM.jpg)
1 min
Rockwell appoints Mariya Prempeh Singapore Country Manager
Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.
![Rockwell appoints Mariya Prempeh Singapore Country Manager](https://reseuro.magzter.com/100x125/articles/11639/1211531/_gMvgS77k1675678561898/ROCKWELL-APPOINTS-MARIYA-PREMPEH-SINGAPORE-COUNTRY-MANAGER.jpg)
1 min
Asieris Pharma appoints Dr Linda Wu as Chief Development Officer
Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising innovative drugs for the treatment of genitourinary tumours and other related diseases, has announced that Linda Wu, PhD will join Asieris as Chief Development Officer.
![Asieris Pharma appoints Dr Linda Wu as Chief Development Officer](https://reseuro.magzter.com/100x125/articles/11639/1211531/bscJ0uFcA1675678518027/ASIERIS-PHARMA-APPOINTS-DR-LINDA-WU-AS-CHIEF-DEVELOPMENT-OFFICER.jpg)
1 min
Chaitanya Sarawate steps in as India MD for Wipro GE Health Care
Wipro GE HealthCare has announced the appointment of Chaitanya Sarawate as the Managing Director (MD), Wipro GE HealthCare and President & CEO, GE HealthCare South Asia.
![Chaitanya Sarawate steps in as India MD for Wipro GE Health Care](https://reseuro.magzter.com/100x125/articles/11639/1211531/r_PmnhcC51675678330047/CHAITANYA-SARAWATE-STEPS-IN-AS-INDIA-MD-FOR-WIPRO-GE-HEALTH-CARE.jpg)
1 min
Former FDA medical device officer joins Pulnovo Medical's scientific advisory board
China-based Pulnovo Medical has announced the appointment of Dr Mingdong Zhang to the company’s Scientific Advisory Board (SAB).
![Former FDA medical device officer joins Pulnovo Medical's scientific advisory board](https://reseuro.magzter.com/100x125/articles/11639/1211531/0YkyqK0tB1675678803778/FORMER-FDA-MEDICAL-DEVICE-OFFICER-JOINS-PULNOVO-MEDICALS-SCIENTIFIC-ADVISORY-BOARD.jpg)
1 min
Dr David John Jeans steps in as HistoIndex's Non-Executive Chairman
Rockwell Automation, dedicated to industrial automation and digital transformation across sectors including pharma and healthcare, has appointed Mariya Prempeh as country manager for Singapore, effective immediately.
![Dr David John Jeans steps in as HistoIndex's Non-Executive Chairman](https://reseuro.magzter.com/100x125/articles/11639/1211531/HwoRUEaDL1675678594185/DR-DAVID-JOHN-JEANS-STEPS-IN-AS-HISTOINDEXS-NONEXECUTIVE-CHAIRMAN.jpg)
1 min
SK Bioscience accelerates global growth strategy by picking talent from Big Pharma
South Korea-based SK bioscience has announced that Richard Kensinger, PhD, former Director and Head of Drug Substance Process Development in SanofiPasteur and former Executive Director of Process Development and Protein Sciences at Affinivax Inc. has joined in ‘SK bioscience USA Inc.’ as Vice President of R&D Project Management. Dr Kensinger is an expert who has been dedicated to biopharmaceutical R&D, working at global companies for more than 20 years.
![SK Bioscience accelerates global growth strategy by picking talent from Big Pharma](https://reseuro.magzter.com/100x125/articles/11639/1211531/WNkXXxFXr1675678654504/SK-BIOSCIENCE-ACCELERATES-GLOBAL-GROWTH-STRATEGY-BY-PICKING-TALENT-FROM-BIG-PHARMA.jpg)
1 min
Australia turns back the clock on damaged heart tissue
An international team of researchers, led by University of Sydney in Australia, has developed a method to reverse the loss of elasticity of damaged heart tissue following heart attacks.
![Australia turns back the clock on damaged heart tissue](https://reseuro.magzter.com/100x125/articles/11639/1211531/89K30pzf91675678848590/AUSTRALIA-TURNS-BACK-THE-CLOCK-ON-DAMAGED-HEART-TISSUE.jpg)
1 min
Singapore demonstrates quantum recoil, paving way for precise X-ray imaging in healthcare
For the first time since it was proposed over 80 years ago, scientists from Nanyang Technological University, Singapore (NTU Singapore) have demonstrated the phenomenon of \"quantum recoil\", which describes how the particle nature of light has a major impact on electrons moving through materials.
![Singapore demonstrates quantum recoil, paving way for precise X-ray imaging in healthcare](https://reseuro.magzter.com/100x125/articles/11639/1211531/nZl2RpWYi1675678933559/SINGAPORE-DEMONSTRATES-QUANTUM-RECOIL-PAVING-WAY-FOR-PRECISE-XRAY-IMAGING-IN-HEALTHCARE.jpg)
1 min
Korea provides new equation to US FDA for improving drug interaction prediction
The US Food and Drug Administration (FDA) recommends indirect evaluation of drug interactions using a formula suggested in their guidance first published in 1997, revised in January of 2020, in order to evaluate drug interactions and minimise side effects of having to use more than one type of drugs at once.
![Korea provides new equation to US FDA for improving drug interaction prediction](https://reseuro.magzter.com/100x125/articles/11639/1211531/cjxkscMIr1675679048455/KOREA-PROVIDES-NEW-EQUATION-TO-US-FDA-FOR-IMPROVING-DRUG-INTERACTION-PREDICTION.jpg)
1 min
Study in NZ, Australia set to change treatment of children with acute respiratory problems
A world-first Australian and New Zealand (NZ) study is set to change how clinicians treat children with acute respiratory problems, improving best care and potentially saving millions of healthcare dollars, particularly in remote, rural and indigenous communities.
![Study in NZ, Australia set to change treatment of children with acute respiratory problems](https://reseuro.magzter.com/100x125/articles/11639/1211531/lu6cusdq31675679101355/STUDY-IN-NZ-AUSTRALIA-SET-TO-CHANGE-TREATMENT-OF-CHILDREN-WITH-ACUTE-RESPIRATORY-PROBLEMS.jpg)
1 min
Shimadzu opens door to biomolecular imaging with new compact MALDI-TOF solution
Japan-headquartered Shimadzu Corporation has announced the release of the world’s smallest MALDI-TOF imaging solution, available as an option on the successful benchtop MALDI-TOF mass spectrometry series: the MALDI-8020 for positive ion analysis and the MALDI-8030, which features a dual-polarity ion source.
![Shimadzu opens door to biomolecular imaging with new compact MALDI-TOF solution](https://reseuro.magzter.com/100x125/articles/11639/1211531/7PQ-ACqB51675679271689/SHIMADZU-OPENS-DOOR-TO-BIOMOLECULAR-IMAGING-WITH-NEW-COMPACT-MALDITOF-SOLUTION.jpg)
1 min
Thermo Fisher unveils CE-IVD marked assay to detect treatment-resistant HIV-1 strains
Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems TaqPath Seq HIV1 Genotyping Kit, a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics.
![Thermo Fisher unveils CE-IVD marked assay to detect treatment-resistant HIV-1 strains](https://reseuro.magzter.com/100x125/articles/11639/1211531/e3HXVD1Za1675679172318/THERMO-FISHER-UNVEILS-CEIVD-MARKED-ASSAY-TO-DETECT-TREATMENTRESISTANT-HIV1-STRAINS.jpg)
1 min
Qiagen launches EZ2 Connect MDx platform for automated sample processing in diagnostic labs
Qiagen has announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the in vitro diagnostic (IVD) platform for automated sample processing available for wide scale use 18 months after being made available for research.
![Qiagen launches EZ2 Connect MDx platform for automated sample processing in diagnostic labs](https://reseuro.magzter.com/100x125/articles/11639/1211531/UQmLEkRpm1675679386475/QIAGEN-LAUNCHES-EZ2-CONNECT-MDX-PLATFORM-FOR-AUTOMATED-SAMPLE-PROCESSING-IN-DIAGNOSTIC-LABS.jpg)
1 min
BioSpectrum Asia Magazine Description:
Publisher: MM Activ Sci-Tech Communication
Category: Business
Language: English
Frequency: Monthly
BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:
* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.
BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.
Cancel Anytime [ No Commitments ]
Digital Only